HBV Mutant YMMDD
May 17, 2002
I am confused. What should somebody start treatment with Epivir if it will cause a mutant virus? I have read here that about 40 of the cases can seroconvert, but do they have to continue treatment for ever, and if so, doesn't it make your body resistant to these drugs, and you will not be able to use them for any other diseases in the future, including AIDS? Thanks
Response from Dr. Fried
Lamivudine (Epivir) is a good drug for the treatment of hepatitis B (one of two drugs approved by the FDA for this indication, interferon is the other one). The issue of YMDD mutations is important and all the questions are not completely resolved. There is evidence to suggest that YMDD HBV mutants are less hardy than the wild-type virus and that levels of HBV DNA and ALT will still be lower than baseline, even after the develment of YMDD. HOWEVER, the long-term consequences of these mutations are not known. New drugs are being developed that work against the YMDD mutants (adefovir is one) and it is likely some combination of drugs, just like HIV therapy, will ultimately be the best regimen. All this needs to be proven in clinical trials.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Pain In Penis After Unprotected Sex Without Ejaculation What Are The Chances Of HIV
- Red Spots After Unprotected Sex Without Ejaculation Worried I Have HIV
- Extreme Watery Vaginal Discharge
- Oral Thrush Pain Relief
- Picture Of Sexually Transmitted Disease Symptoms
- Vaginal Pressure Prickling And Tingling
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.